Market Tracker

11/22 9:50am ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6299
Delayed Data
As of 9:33am ET
 +0.0049 / +0.78%
Today’s Change
0.32
Today|||52-Week Range
2.42
-11.87%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.63
Today’s open0.63
Day’s range0.63 - 0.63
Volume7,111
Average volume (3 months)330,809
Market cap$14.8M
Dividend yield--
Data as of 9:33am ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+44.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...+0.00+0.16%
NDRAENDRA Life Sciences ...+0.10+3.45%
SNGXSoligenix Inc0.000.00%
CURNeuralstem Inc-0.04-3.77%
Data as of 9:48am ET, 11/22/2017

Financials

Next reporting dateMarch 29, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts